Curiteva

Curiteva is a private, commercial-stage medical device company specializing in 3D-printed spinal implants, with a core focus on its proprietary porous PEEK technology. The company's flagship Inspire® platform is designed to enhance osseointegration through a fully interconnected porous structure and a hydrophilic surface, positioning it as a differentiated player in the spine market. With an expanding product portfolio that includes interbody fusion devices, fixation systems, and bone graft substitutes, Curiteva is targeting the large and growing global spinal implant market. Its recent FDA designations and reported clinical use indicate progress in regulatory and commercial adoption.

Proprietary 3D printing platform for creating fully porous, trabecular PEEK spinal implants with a bioactive hydrophilic surface treatment (HA FUSE) designed to promote osseointegration. The platform includes custom hardware, software, firmware, and slicing algorithms.

Curiteva competes in the crowded spinal implant market against giants like Medtronic, Stryker, and Johnson & Johnson, as well as other spine-focused players like NuVasive and Globus Medical. Its primary differentiation is its proprietary 3D-printed fully porous PEEK, competing against traditional solid PEEK/titanium and other porous materials like 3D-printed titanium.